Emergency Management of Oral Hypoglycemic Drug Toxicity

Emergency Medicine Clinics of North America

Volumn 25, Issue 2, 2007, Pages 347-356

  Rowden, Adam K ^a   Fasano, Charles J ^a,b  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ACTIVATED CARBON; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; DIAZOXIDE; GLIBENCLAMIDE; GLIPIZIDE; GLITAZONE DERIVATIVE; GLUCAGON; GLUCOSE; INSULIN; METFORMIN; NATEGLINIDE; OCTREOTIDE; REPAGLINIDE; SULFONYLUREA; TOLBUTAMIDE;

BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG CLEARANCE; DRUG INHIBITION; DRUG INTOXICATION; DRUG MECHANISM; EMERGENCY PHYSICIAN; EMERGENCY TREATMENT; GLUCOSE BLOOD LEVEL; HALF LIFE TIME; HEMODIALYSIS; HEPATITIS; HUMAN; HYPOGLYCEMIA; HYPOTENSION; LACTIC ACIDOSIS; LIVER FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; POISON CENTER; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SINGLE DRUG DOSE;

EID: 34247557586     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2007.02.010     Document Type: Review

References (76)

1. William A. Watson, George C. Rodgers Jr, Jessica Youniss, et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2005;23(5):589-666.
2. Eliasson L., Renstrom E., Ammala C., et al. PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells. Science 271 5250 (1996) 813-815
3. Carlton Jr. F.B. Recent advances in the pharmacologic management of diabetes mellitus. Emerg Med Clin North Am 18 4 (2000) 745-753
4. Harrigan R.A., Nathan M.S., and Beattie P. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment. Ann Emerg Med 38 1 (2001) 68-78
5. Palatnick W., Meatherall R.C., and Tenenbein M. Clinical spectrum of sulfonylurea overdose and experience with diazoxide therapy. Arch Intern Med 151 9 (1991) 1859-1862
6. Ciechanowski K., Borowiak K.S., Potocka B.A., et al. Chlorpropamide toxicity with survival despite 27-day hypoglycemia. J Toxicol Clin Toxicol 37 7 (1999) 869-871
7. Chelliah A., and Burge M.R. Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention. Drugs Aging 21 8 (2004) 511-530
8. Spiller H.A., and Sawyer T.S. Toxicology of oral antidiabetic medications. Am J Health Syst Pharm 63 10 (2006) 929-938
9. Osterhoudt K.C. This treat is not so sweet: exploratory sulfonylurea ingestion by a toddler. Pediatr Case Rev 3 4 (2003) 215-217
10. Seltzer H.S. Drug-induced hypoglycemia. A review of 1418 cases. Endocrinol Metab Clin North Am 18 1 (1989) 163-183
11. Spiller H.A., Villalobos D., Krenzelok E.P., et al. Prospective multicenter study of sulfonylurea ingestion in children. J Pediatr 131 1 Pt 1 (1997) 141-146
12. Quadrani D.A., Spiller H.A., and Widder P. Five year retrospective evaluation of sulfonylurea ingestion in children. J Toxicol Clin Toxicol 34 3 (1996) 267-270
13. Szlatenyi C.S., Capes K.F., and Wang R.Y. Delayed hypoglycemia in a child after ingestion of a single glipizide tablet. Ann Emerg Med 31 6 (1998) 773-776
14. Borowski H., Caraccio T., and Mofenson H. Sulfonylurea ingestion in children: is an 8-hour observation period sufficient?. J Pediatr 133 4 (1998) 584-585
15. Waickus C.M., de Bustros A., and Shakil A. Recognizing factitious hypoglycemia in the family practice setting. J Am Board Fam Pract 12 2 (1999) 133-136
16. Shumak S.L., Corenblum B., and Steiner G. Recurrent hypoglycemia secondary to drug-dispensing error. Arch Intern Med 151 9 (1991) 1877-1878
17. Sledge E.D., and Broadstone V.L. Hypoglycemia due to a pharmacy dispensing error. South Med J 86 11 (1993) 1272-1273
18. Goudie A.M., and Kaye J.M. Contaminated medication precipitating hypoglycaemia. Med J Aust 175 5 (2001) 256-257
19. Ben-Chetrit E., and Melmed R.N. Recurrent hypoglycaemia in multiple myeloma: a case of Munchausen syndrome by proxy in an elderly patient. J Intern Med 244 2 (1998) 175-178
20. Fernando R. Homicidal poisoning with glibenclamide. Med Sci Law 39 4 (1999) 354-358
21. Owen L., Ellis M., and Shield J. Deliberate sulphonylurea poisoning mimicking hyperinsulinaemia of infancy. Arch Dis Child 82 5 (2000) 392-393
22. Trenque T., Hoizey G., and Lamiable D. Serious hypoglycemia: Munchausen's syndrome?. Diabetes Care 24 4 (2001) 792-793
23. Hoizey G., Lamiable D., Trenque T., et al. Identification and quantification of 8 sulfonylureas with clinical toxicology interest by liquid chromatography-ion-trap tandem mass spectrometry and library searching. Clin Chem 51 9 (2005) 1666-1672
24. Earle K.E., Rushakoff R.J., and Goldfine I.D. Inadvertent sulfonylurea overdosage and hypoglycemia in an elderly woman: failure of serum hypoglycemia screening. Diabetes Technol Ther 5 3 (2003) 449-451
25. Klonoff D.C. A flaw in the use of sulfonylurea screening to diagnose sulfonylurea overdosages. Diabetes Technol Ther 5 3 (2003) 453-454
26. Hirshberg B., Skarulis M.C., Pucino F., et al. Repaglinide-induced factitious hypoglycemia. J Clin Endocrinol Metab 86 2 (2001) 475-477
27. Nakayama S., Hirose T., Watada H., et al. Hypoglycemia following a nateglinide overdose in a suicide attempt. Diabetes Care 28 1 (2005) 227-228
28. Nagai T., Imamura M., Iizuka K., et al. Hypoglycemia due to nateglinide administration in diabetic patient with chronic renal failure. Diabetes Res Clin Pract 59 3 (2003) 191-194
29. Fonseca V.A., Kelley D.E., Cefalu W., et al. Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus. Metabolism 53 10 (2004) 1331-1335
30. Kannisto H., and Neuvonen P.J. Adsorption of sulfonylureas onto activated charcoal in vitro. J Pharm Sci 73 2 (1984) 253-256
31. Kivisto K.T., and Neuvonen P.J. The effect of cholestyramine and activated charcoal on glipizide absorption. Br J Clin Pharmacol 30 5 (1990) 733-736
32. Ludwig S.M., McKenzie J., and Faiman C. Chlorpropamide overdose in renal failure: management with charcoal hemoperfusion. Am J Kidney Dis 10 6 (1987) 457-460
33. Service F.J. Hypoglycemic disorders. N Engl J Med 332 17 (1995) 1144-1152
34. Shorr R.I., Ray W.A., Daugherty J.R., et al. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 157 15 (1997) 1681-1686
35. Barennes H., Valea I., Nagot N., et al. Sublingual sugar administration as an alternative to intravenous dextrose administration to correct hypoglycemia among children in the tropics. Pediatrics 116 5 (2005) e648-e653
36. Muhlhauser I., Toth G., Sawicki P.T., et al. Severe hypoglycemia in type I diabetic patients with impaired kidney function. Diabetes Care 14 4 (1991) 344-346
37. Katz M.D., and Erstad B.L. Octreotide, a new somatostatin analogue. Clin Pharm 8 4 (1989) 255-273
38. Boyle P.J., Justice K., Krentz A.J., et al. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. J Clin Endocrinol Metab 76 3 (1993) 752-756
39. Crawford B.A., and Perera C. Octreotide treatment for sulfonylurea-induced hypoglycaemia. Med J Aust 180 10 (2004) 540-541 [author reply 541]
40. McLaughlin S.A., Crandall C.S., and McKinney P.E. Octreotide: an antidote for sulfonylurea-induced hypoglycemia. Ann Emerg Med 36 2 (2000) 133-138
41. Schier J.G., Hirsch O.N., and Chu J. Octreotide as antidote for sulfonylurea-induced hypoglycemia. Ann Emerg Med 37 4 (2001) 417-418
42. Carr R., and Zed P.J. Octreotide for sulfonylurea-induced hypoglycemia following overdose. The Annals of Pharmacotherapy 36 11 (2002) 1727-1732
43. Green R.S., and Palatnick W. Effectiveness of octreotide in a case of refractory sulfonylurea-induced hypoglycemia. J Emerg Med 25 3 (2003) 283-287
44. Tenenbein M. Recent advancements in pediatric toxicology. Pediatr Clin North Am 46 6 (1999) 1179-1188 vii
45. Krentz A.J., Boyle P.J., Macdonald L.M., et al. Octreotide: a long-acting inhibitor of endogenous hormone secretion for human metabolic investigations. Metabolism 43 1 (1994) 24-31
46. Ries N.L., and Dart R.C. New developments in antidotes. Med Clin North Am 89 6 (2005) 1379-1397
47. Spiller H.A. Management of antidiabetic medications in overdose. Drug Saf 19 5 (1998) 411-424
48. Fasano C.J., and O'Malley G.F. A prospective trial of octreotide vs. placebo in sulfonylurea-associated hypoglycemia. Acad Emerg Med 13 (2006) 180
49. Lheureux P.E., Zahir S., Penaloza A., et al. Bench-to-bedside review: antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide. Crit Care 9 6 (2005) 543-549
50. Carstens S., and Sprehn M. Prehospital treatment of severe hypoglycaemia: a comparison of intramuscular glucagon and intravenous glucose. Prehospital Disaster Med 13 2-4 (1998) 44-50
51. Howell M.A., and Guly H.R. A comparison of glucagon and glucose in prehospital hypoglycaemia. J Accid Emerg Med 14 1 (1997) 30-32
52. Vukmir R.B., Paris P.M., and Yealy D.M. Glucagon: prehospital therapy for hypoglycemia. Ann Emerg Med 20 4 (1991) 375-379
53. Rosenfalck A.M., Bendtson I., Jorgensen S., et al. Nasal glucagon in the treatment of hypoglycaemia in type 1 (insulin-dependent) diabetic patients. Diabetes Res Clin Pract 17 1 (1992) 43-50
54. Slama G., Alamowitch C., Desplanque N., et al. A new non-invasive method for treating insulin-reaction: intranasal lyophylized glucagon. Diabetologia 33 11 (1990) 671-674
55. Stenninger E., and Aman J. Intranasal glucagon treatment relieves hypoglycaemia in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36 10 (1993) 931-935
56. Stumvoll M., Nurjhan N., Perriello G., et al. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 333 9 (1995) 550-554
57. Bailey C.J., and Turner R.C. Metformin. N Engl J Med 334 9 (1996) 574-579
58. Spiller H.A., and Quadrani D.A. Toxic effects from metformin exposure. Ann Pharmacother 38 5 (2004) 776-780
59. Spiller H.A., Weber J.A., Winter M.L., et al. Multicenter case series of pediatric metformin ingestion. Ann Pharmacother 34 12 (2000) 1385-1388
60. von Mach M.A., Sauer O., and Sacha Weilemann L. Experiences of a poison center with metformin-associated lactic acidosis. Exp Clin Endocrinol Diabetes 112 4 (2004) 187-190
61. Chan N.N., Brain H.P., and Feher M.D. Metformin-associated lactic acidosis: a rare or very rare clinical entity?. Diabet Med 16 4 (1999) 273-281
62. Thomsen H.S. How to avoid CIN: guidelines from the European Society of Urogenital Radiology. Nephrol Dial Transplant 20 suppl 1 (2005) i18-i22
63. Brady W.J., and Carter C.T. Metformin overdose. Am J Emerg Med 15 1 (1997) 107-108
64. Chang C.T., Chen Y.C., Fang J.T., et al. High anion gap metabolic acidosis in suicide: don't forget metformin intoxication-two patients' experiences. Ren Fail 24 5 (2002) 671-675
65. Gjedde S., Christiansen A., Pedersen S.B., et al. Survival following a metformin overdose of 63 g: a case report. Pharmacol Toxicol 93 2 (2003) 98-99
66. Guo P.Y., Storsley L.J., and Finkle S.N. Severe lactic acidosis treated with prolonged hemodialysis: recovery after massive overdoses of metformin. Semin Dial 19 1 (2006) 80-83
67. Harvey B., Hickman C., Hinson G., et al. Severe lactic acidosis complicating metformin overdose successfully treated with high-volume venovenous hemofiltration and aggressive alkalinization. Pediatr Crit Care Med 6 5 (2005) 598-601
68. Heaney D., Majid A., and Junor B. Bicarbonate haemodialysis as a treatment of metformin overdose. Nephrol Dial Transplant 12 5 (1997) 1046-1047
69. Lacher M., Hermanns-Clausen M., Haeffner K., et al. Severe metformin intoxication with lactic acidosis in an adolescent. Eur J Pediatr 164 6 (2005) 362-365
70. McLelland J. Recovery from metformin overdose. Diabet Med 2 5 (1985) 410-411
71. Nisse P., Mathieu-Nolf M., Deveaux M., et al. A fatal case of metformin poisoning. J Toxicol Clin Toxicol 41 7 (2003) 1035-1036
72. Lalau J.D., Andrejak M., Moriniere P., et al. Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination. Int J Clin Pharmacol Ther Toxicol 27 6 (1989) 285-288
73. Teale K.F., Devine A., Stewart H., et al. The management of metformin overdose. Anaesthesia 53 7 (1998) 698-701
74. Barrueto F., Meggs W.J., and Barchman M.J. Clearance of metformin by hemofiltration in overdose. J Toxicol Clin Toxicol 40 2 (2002) 177-180
75. Barquero Romero J., and Perez Miranda M. Metformin-induced cholestatic hepatitis. Gastroenterol Hepatol 28 4 (2005) 257-258
76. Panzer U., Kluge S., Kreymann G., et al. Combination of intermittent haemodialysis and high-volume continuous haemofiltration for the treatment of severe metformin-induced lactic acidosis. Nephrol Dial Transplant 19 8 (2004) 2157-2158